Ntụziaka maka ị drugsụ ọgwụ, analogues, nyocha

Insulin lyspro bụ nnwale insulin nke mmadụ. Lyspro insulin dị iche na insulin nke mmadụ n’usoro nke proline na nsị nke lysine amino acid nọ n’ọkwa 28 na 29 n’ime agịga insulin B. Lyspro insulin na - edozi metabolism nke glucose. Ọzọkwa, insulin lyspro nwere ọgwụ anti-catabolic na anabolic na anụ ahụ dị iche iche. Na anụ ahụ, ọdịnaya nke glycogen, abụba abụba, glycerol na-abawanye, enwere mmụba na amino acid na protein protein na-abawanye, mana nke a na-ebelata gluconeogenesis, glycogenolysis, lipolysis, ketogenesis, catabolism protein na ịhapụ amino acid. E gosipụtara insulin Lyspro ka ọ bụrụ inshalar na insulin nke mmadụ. E jiri ya tụnyere nhazi insulin na-eme obere oge, a na-eji insulin lispro ngwa ngwa mmalite na njedebe nke nsonaazụ ahụ. Nke a bụ n'ihi mmụba dị ukwuu site na ebutu nke subcutaneous n'ihi na ichekwa ihe monomeric Ọdịdị nke lyspro insulin molecules na usọ. Nkeji iri na ise mgbe nchịkwa subcutaneous gasịrị, a na-ahụzi mmetụta insulin lispro, a na-ahụ mmetụta kachasị n'etiti awa 0,5 na awa 2.5, oge ọrụ ahụ bụ awa 3-4. N'ime ndị ọrịa nwere ụdị ọrịa shuga 1 na ụdị nke ọrịa shuga, hyperglycemia nke na-apụta mgbe nri ga-agbadata karịa mgbe ị na-eji insulin lyspro eme ihe ma e jiri ya tụnyere insulin nke mmadụ na-arịa. Maka ndị ọrịa na-anata insalins na obere nwa, a ga-ahọpụta otu ọgwụ abụọ iji wee nweta ogo glucose ọbara dị mma ụbọchị dum. Ogologo oge nke insulin lispro, maka nkwadebe insulin niile, nwere ike ịdị iche na ndị ọrịa dị iche iche ma ọ bụ n'oge dị iche iche na otu onye ahụ ma dabere na nha, ọkọnọ ọbara ọbara, ebe a na-agbanye ahụ, mmega ahụ na oke ahụ. Ngwa ọgwụ ọgwụ insulin lyspro dị na ụmụaka yiri nke a hụrụ na ndị okenye. N'ime ndị ọrịa nwere ụdị ọrịa shuga 2 nke na-enweta ihe kachasị mkpa nke usoro sulfonylurea, mgbakwunye nke insulin lyspro na-eduga ná mbelata nke ukwuu na haemoglobin glycosylated n'ụdị ndị a. Lyspro insulin maka ndị ọrịa nwere ụdị 1 na ụdị shuga 2 na-esobelata ọnụ ọgụgụ nke ọrịa hypoglycemia. Nzaghachi glucodynamic na insulin lyspro nọọrọ onwe ya nke imeju ma ọ bụ ọrụ akụrụ.
Mgbe etinyere subcutaneously, a na-etinye insulin insulin ngwa ngwa wee rute n'ọtụtụ kachasị n'ọbara mgbe oge 30 - 70 gasịrị. Olu nke ikesa insulin lispro bụ 0.26 - 0.36 l / n'arọ yana ya na olu nke nkesa insulin mmadụ na-adị. Ọkara ndụ insulin lyspro nwere nchịkwa subcutaneous bụ ihe dịka elekere 1. N'ime ndị ọrịa nwere ọrịa umeji na / ma ọ bụ akụrụ, ọnụ ọgụgụ dị elu nke nnabata insulin lispro na-adịgide ma e jiri ya tụnyere insulin nke mmadụ.

1dị shuga 1 bụ mellitus (nke na-agbanye insulin), chọrọ ọgwụ insulin iji nọgide na-enwe ọ̀tụ̀tụ̀ glucose ọbara nkịtị, gụnyere ịnagide nkwadebe insulin ndị ọzọ, nrụgide ọgwụ subcutaneous nke ukwuu (mbibi insulin nke ime obodo), postprandial hyperglycemia, nke na-enweghị ike ịkwado insulin ndị ọzọ.
Diabetesdị nke abụọ nke ọrịa shuga mellitus (nke na-abụghị insulin), na-achọ ọgwụgwọ insulin iji nọgide na-enwe ọ̀tụ̀tụ̀ glucose ọbara dị ala: na mmịnye nke nkwadebe insulin ndị ọzọ, iguzogide ọgwụ hypoglycemic ọgwụ, hypglycemia postprandial nke a na-apụghị ịkọwa akọwa, na ọrịa ndị na-emetụta onwe ya.

Nlekọta insulin Lyspro na usoro onunu ogwu

A na-ahụ insulin Lyspro subcutaneously, intramuscularly na intravenly 5 ruo 15 nkeji tupu nri. A na-edobe usoro usoro onunu ogwu ya na uzo ochichi ya n’otu n’otu.
Enwere ike inye insulin Lyspro obere oge tupu nri. Ọ bụrụ na ọ dị mkpa, enwere ike inye insulin Lyspro obere oge ka nri gasịrị.
E kwesiri inye onye ọrịa ọzụzụ n'ụzọ ziri ezi. E kwesịrị iji ụzọ ọzọ banye n’apata ụkwụ, ubu, afọ ma ọ bụ n’akụkụ ụkwụ. Ekwesịrị ịgbanye saịtị ndị injection ahụ ka ejiri otu ebe ahụ karịa otu ugboro n'ọnwa. Site na nchịkwa insulin lyspro dị n'okpuru ala, ekwesịrị ịkpachara anya iji zere itinye ọgwụ ahụ n'ime arịa ọbara. Mgbe ogwu ogbugba gasịrị, ekwesighi ịhịa aka ntụtụ.
Ọ bụrụ na ọ dị mkpa (ọrịa siri ike, ketoacidosis, oge dị n'etiti arụmọrụ ma ọ bụ oge ọrụ), a ga-elekọta insulin lispro.
Ọ dị mkpa iji nlezianya leruo ụzọ nchịkwa anya, nke ezubere maka ụdị ọgwụ insulin lispro ji eme ihe.
Imeghari dose mgbe ị na-ebufe ndị ọrịa na insulin lyspro na njikere insulin na-eme ngwa ngwa nke anụmanụ. Mgbanwe na arụmọrụ, ika (onye na-emepụta), ụdị, ụdị, usoro nke insulin na-eduga nwere ike iduga na ọ dị mkpa maka mgbanwe dose. Ekwesịrị itinyefe ndị ọrịa n'otu ụdị insulin gaa na nke ọzọ n'okpuru nlekọta ahụike siri ike, yana ndị ọrịa na-anata insulin kwa ụbọchị nke ihe karịrị 100 nkeji n'ụlọ ọgwụ.
Site na nrụgide mmetụta uche, n'oge ọrịa na-efe efe, n'oge ị additionalụ ọgwụ ndị ọzọ nwere ọrụ hyperglycemic (glucocorticoids, homonụ thyroid, thiazide diuretics, ọgwụ mgbochi), na-abawanye ụba nke carbohydrates na nri, mkpa insulin nwere ike ịba ụba.
Mkpa insulin nwere ike ibelata yana mbelata nke carbohydrates na nri, imeju na / ma ọ bụ akụrụ (n'ihi mbelata gluconeogenesis na insulin metabolism), mụbara ọrụ anụ ahụ, iji ọgwụ ndị ọzọ na-arụ ọrụ hypoglycemic (ndị na-abụghị ndị na-ahọrọ beta-blockers, monoamine oxidase inhibitors, sulfonamides). Mana n'ime ndị ọrịa nwere ọrịa imeju na-adịghị ala ala, ịmụba insulin na-arị elu nwere ike ibute mmụba nke insulin.
Ọnọdụ ebe ngosipụta ịdọ aka ná ntị mbụ banyere hypoglycemia nwere ike ịkọwapụta na enweghị insulin na-agụnye ọgwụgwọ kpụ ọkụ n'ọnụ na insulin, ọnụnọ nke ọrịa shuga mellitus, ọrịa nke usoro ụjọ na-arịa ọrịa shuga mellitus, na iji ọgwụ, dị ka beta-blockers.
N'ime ndị ọrịa nwere hypoglycemia, mgbe nnyefe site na insulin anụmanụ na insulin mmadụ, akara ngosipụta mbụ nke hypoglycemia nwere ike ịdị iche na ndị nwere usoro ọgwụgwọ na insulin ha gara aga. Mgbanwe hyperglycemic na-agbanweghị agbanwe ma ọ bụ mmeghachi omume hypoglycemic nwere ike ibute nsụhọ mmadụ, onye, ọnwụ.
Ojiji nke iji usoro ezughị ezu ma ọ bụ ịkwụsị ọgwụgwọ, karịsịa na ndị ọrịa nwere ụdị ọrịa shuga 1, nwere ike ibute hyperglycemia na ọrịa shuga ketoacidosis, nke nwere ike itinye ndụ onye ọrịa n'ihe egwu.
Enwere ike ịchọ ndozi dose ma ọ bụrụ na nri onye nkịtị na-agbanwe ma ọ bụ na-emega ahụ. Mgbatị ahụ ozugbo ị rie nri nwere ike ịbawanye ohere ịba ụba hypoglycemia.
Mgbe ị na-eji nkwadebe insulin na ọgwụ nke thiazolidinedione otu, ihe ize ndụ nke ịmalite ọrịa edema na obi na-adịghị ala ala na-abawanye, karịsịa na ndị ọrịa nwere ọrịa nke usoro obi na ọnụnọ nke ihe ndị dị ize ndụ maka ọdịda obi na-adịghị ala ala.
Ọsọ nke mmeghachi omume na ike onye ọrịa nwere itinye uche nwere ike imebi hyperglycemia ma ọ bụ hypoglycemia, nke ejikọtara na usoro ezighi ezi nke insulin lispro, nke nwere ike ịdị ize ndụ n'ọnọdụ ọnọdụ ikike ndị a dị oke mkpa (dịka ọmụmaatụ, iji usoro, ụgbọ ala na ụgbọala eme ihe na-adịghị mma. ndị ọzọ). Ọ dị mkpa ka ndị ọrịa kpachara anya iji zere hypoglycemia mgbe ha na-akwọ ụgbọala ma ọ bụ na-arụ ọrụ ebe achọrọ ịbawanye ụba na ọsọ nke mmeghachi omume psychomotor. Nke a dị ezigbo mkpa maka ndị ọrịa ahụ na-enweghị ma ọ bụ belata mmetụta nke prognostic mgbaàmà nke hypoglycemia ma ọ bụ ebe a na-ahụkarị oge ọrịa hypoglycemia. N'ọnọdụ ndị a, ekwesịrị ịtụle maka ịrụ ọrụ dị mkpa chọrọ itinye uche nlebara anya na ọsọ nke ihe omume psychomotor, gụnyere ịkwọ ụgbọala.
Ihe ngbanwe
Hypersensitivity, hypoglycemia.

Ime na lactation

N'oge a, ọnweghị mmetụta Lyspro insulin na-atụrụ ime ma ọ bụ ahụike nke nwa ebu n’afọ na amụrụ. Amaghị ọmụmụ ihe ndị metụtara ọrịa taa. N'oge afọ ime, isi ihe bụ ijikwa glycemic njikwa na ndị ọrịa nwere ọrịa shuga na-anata ọgwụgwọ insulin. Mkpa insulin n'oge ime na-ebelata na ọnwa atọ ma na-abawanye na nke abụọ na nke atọ. Mkpa insulin nwere ike ibelata nke ukwuu n’oge a na-amụ nwa ma ozugbo ọ mụsịrị. Ndị ọrịa nwere ọrịa shuga kwesịrị ịkpọtụrụ dọkịta ma ha tụrụ ime ma ọ bụ mee atụmatụ ịtụrụ ime. N'oge ime ụmụ nwanyị nwere ọrịa shuga, isi ihe bụ nlezianya nyochaa glucose na ahụike niile. Amabeghị ma insịl insulin na-abanye n'ọtụtụ nnukwu mmiri ara. N'ime ndị ọrịa nwere ọrịa mellitus n'oge ị na-a breastụ ara, enwere ike ịchọ mgbanwe insulin na / ma ọ bụ nri.

Nsonaazụ insulin lyspro

Hypoglycemia (ọsụsọ dị ukwuu, pallor, palpitations, nsogbu nke ụra, ịma jijiji, nsogbu akwara), hypoglycemic precoma na coma (gụnyere nsonaazụ na-egbu egbu), njehie na-emegharị ahụ, mmeghachi omume nfụkasị (mpaghara - redness, ọzịza, itching na injection site, juputara - urticaria, itching ofụri idem, angioedema, mkpụmkpụ ume, fever, mbelata ọbara, ubara mmụba, tachycardia), lipodystrophy, edema.

Mmekọrịta nke insulin lispro na ihe ndị ọzọ

Amprenavir, betamethasone, hydrocortisone, hydrochlorothiazide, glucocorticosteroids, danazole, diazoxide, dexamethasone, isoniazid, nicotinic acid, salbutamol, terbutaline, rhytodrin, ọgwụ mgbochi, onu ogwu antihyretide, trenia antipyretide na-akụda mmetụta nke insulin lyspro, ọ ga - ekwe omume mmepe nke hyperglycemia, mmụba na dose nke insulin lispro.
Acetylsalicylic acid, bisoprolol, ọgwụ mgbochi sulfanilamide, captopril, ụfọdụ antidepressants (monoamine oxidase inhibitors), beta-blockers, octreotide, phenfluramine, enalapril, acarbose, anabolic steroid, tetracyclines, guanorotin agenitrogen inagonitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors, inhibitors inhibitors , ọgwụ ethanol na ọgwụ ethanol nwere mmụba nke insulin lispro.
Diclofenac na-agbanwe mmetụta nke insulin lispro, ịchịkwa glucose ọbara dị mkpa.
Mgbe ejikọtara ya na insulin, lyspro beta-blockers, clonidine, reserpine, bisoprolol nwere ike zoo ngosipụta nke ọrịa hypoglycemia.
Ekwesighi ịgwakọta insulin Lyspro na nhazi insulin anụmanụ.
Na ntinye nke dọkịta, enwere ike iji insulin Lyspro mee ihe na njikọta insulin nke mmadụ na-adị ogologo oge ma ọ bụ site na nkwuputa ọnụ na-enye nkọ.
Mgbe ị na-eji ọgwụ ndị ọzọ nwere insulin insulin, gwa dọkịta gị.

Dodoụbiga ya ókè

N'ihe banyere ịdoụ ọgwụ insulin na lyspro, hypoglycemia malitere: ịda mba, agụụ, ọsụsọ, ịma jijiji, isi ọwụwa, tachycardia, ọgbụgbọ, ọgbụgbọ, ọhụhụ na-adịghị mma, ọgba aghara, coma, ọnwụ.
A na-akwụsị oge dị ala nke hypoglycemia site na ịba ụba nke glucose, shuga, ngwaahịa nwere shuga (a na-agwa onye ọrịa ahụ mgbe ọ dịkarịa ala 20 gcose ya)
Enwere ike imezi hypoglycemia dị mkpirikpi site na iji subcutaneous ma ọ bụ nchịkwa intramuscular nke glucagon yana ịba ụba nke carbohydrates mgbe edozi ọnọdụ onye ọrịa, dextrose (glucose) a na-achịkwa ya n'ọbara nye ndị ọrịa na-anaghị anabata glucagon.
Ọ bụrụ na onye ọrịa nọ na nkụma, mgbe ahụ subcutaneous ma ọ bụ intramuscular management nke glucagon dị mkpa, na anọghị glucagon ma ọ bụ mmeghachi omume na nchịkwa ya, ekwesịrị inye nlekọta nke dextrose intravenously, mgbe mweghachi nke nsụhọ, a ga-enye onye ọrịa nri nri bara ụba na carbohydrates, inyochakwu onye ọrịa ahụ na ị carbohydụ ya na carbohydrate dị mkpa maka igbochi nlọghachi nke hypoglycemia, ọ dị mkpa ịgwa ndị dibịa bekee banyere hypoglycemia gara aga.

Nkọwapụta ọgwụ ọjọọ

N’adịghị ka insulin ọgwụ ndị ọzọ na-eme obere oge, Insulin Lizpro na-amalite ma kwụsị mmetụta ya ngwa ngwa. Mmetụta dị otú ahụ nke ọgwụ ahụ na-esite na ngwa ngwa nke absorption, yabụ ị nwere ike were ya ozugbo tupu ị rie nri. Ọnụọgụ mmịpụta na mmalite mkpughe na-emetụta ọnọdụ nọ n'ahụ ahụ eji arụ ọrụ. Ọgwụ na-arụ ọrụ kachasị na ọkara otu elekere mgbe nchịkwa, na-ejigide ọkwa a ruo elekere abụọ. N'ime ahụ, ọgwụ nwere ihe ruru elekere anọ.

N’ime ihe mebere ya, “Insulin Lizpro” nwere otu ihe eji arụ ọrụ nke nwere arụ ọrụ, yana ụfọdụ ihe inyeaka na mmiri. Ogwu ahu n’agha bu uzo ogwu n’ezi ogwu nke edoziri n’agha na n’iru. Ọgwụ insulin Lizpro "na-akwakọba na igbe kaadiboodu na blisters ma ọ bụ mkpịsị mkpụrụ pụrụ iche nwere katrized ise nke 3 ml nke ihe ngwọta.

Edebere "Insulin Lizpro":

ọrịa shuga 1, ọ bụrụ na anụghị anabata ihe ndị ọzọ.
ịba ụba glucose na ahụ, nke insulins ndị ọzọ anaghị agbazi,
Ọrịa shuga 2, ọ bụrụ na ọ gaghị ekwe omume ị pụ ọgwụ iji wedata shuga ọbara,
ekwe omume iwelata mmebi nke anụ ahụ nke insulins ndị ọzọ,
ịwa ahụ
ọnụnọ nke ọnya na-arịa ọrịa mellitus concom

Usoro ọgwụgwọ nke ọgwụ "Insulin Lizpro" nke dọkịta kwuru ka enye ya. A na-agbakọ ya dabere n'ọbara glucose ọbara gị. A ga-abawanye kwa ụbọchị ma ọ bụrụ na onye ọrịa nwere ọrịa na-efe efe, mmụba nke nrụgide mmetụta uche, mmụba nke ụba carbohydrates na nri, na mgbanwe na mgbatị anụ ahụ. Ide akwụkwọ kwere omume na njikọ ndị ọzọ.

Isiokwu ndị ọkachamara banyere ahụ ike

Nkwadebe insulin dị mkpa maka ndị ọrịa nwere ọrịa shuga 1 na 40% nke ndị ọrịa nwere ụdị ọrịa nke abụọ.Insulin bụ homonụ polypeptide. Dịka iwu, a na-achịkwa ọgwụ ọgwụ na subcutaneously, mana n'ọnọdụ ọnọdụ mberede, enwere ike ịnwe intramuscular ma ọ bụ nchịkwa ọgbụgba. Nsonye ya na-adabere kpọmkwem na saịtị ịgba ahụ, ọrụ akwara, njirimara usoro ọbara na usoro ntụtụ.

Ingkpọtụrụ ndị na - anabata mkpụrụ ndụ, homonụ ahụ na - amalite ịwa ahụ:

Ọkpụkpụ ọbara glucose dị ala.
Ntughari njikọ nke glycogen.
Mwepu nke okike nke aru ketone.
Ihe mgbochi nke ike shuga site na ogige ndị na-abụghị carbohydrate.
Nmepụta usoro nke triglycerides na obere lipoproteins dị ala.
Ihe mgbochi nke oke abụba n'ihi ihi abụba sitere na carbohydrates.
Na-akpali mmepụta nke glycogen, nke na-arụ ọrụ dị ka ikike ichekwa ahụ.

Ejiri usoro ọgwụgwọ insulin mee ihe site na mbido ha:

1. Anụmanụ (anụ ezi) - Gulul insulin, Ultralente, Ultralente MS, Monodar Ultralong, Monodar Long, Monodar K, Monosuinsulin.
2. Humanmụ mmadụ (injin na-arụ ọrụ na mkpụrụ ndụ ihe nketa) - Actrapid, Novorapid, Lantus, Humulin, Humalog, Novomiks, Protafan.
3. Analogues na sịntetik - Lizpro, Aspart, Glargin, Detemir.

Ekekọrịta ọgwụ site na oge ọrụ:

Ultrashort insulin

Na-anabata ngwa ngwa karịa ụdị ọgwụ ndị ọzọ. Ọ na - amalite ime nkeji 10 ruo 20 mgbe nchịkwa gachara, na - ebute mbelata ọbara shuga. Mmetụta kachasị na-etolite n'ime nkeji 30-180 ma na-adịgide ruo awa 3-5.

Ngwakọta okpukpu abụọ nke insulin na-agba ọsọ na nkwụsị protamine nke oge ọkara. Ọgwụ bụ analog nke ihe ana - eme mmadụ, nke na - emetụta ọdịiche nke proline na nsị nke amị acid. Na -emezi usoro glucose ma nwee mmetụta anabolic.

Yiri insulin na insulin mmadụ. Etmalite imeghari akwara ike mee ka ntughari glucose na amino acid banye n’abuba. Ọ na-ewe oge nkeji iri na ise mgbe nchịkwa gachara. Okwa nke riri oke na enyere gi aka iji ogwu ahu ozugbo tupu iri nri.

Ihe ngosiputa eji eme ihe: mellitus oria shuga nke udiri mbu, anabataghi ogwu nke ozo ozo, postprandial hyperglycemia (enweghi ike idozi ya), mmebi obodo nke pesiri puru iche. Ọrịa shuga 2dị nke abụọ, iguzogide ọgwụ mgbochi hypoglycemic nke ọrịa, ọrịa mgbochi, ịwa ahụ.
Ofzọ itinye ya n'ọrụ na usoro onunu ogwu: a na-ekpebi n’otu n’otu maka onye ọrịa ọ bụla, dabere n’odụkọta glycemia n’ime ọbara. A na-eji ọgwụ ahụ eme ihe naanị. Ọ bụrụ na ọ dị mkpa, enwere ike ijikọ ya na ọgwụ ogologo ma ọ bụ sulfonylureas maka nchịkwa ọnụ.
Contraindications: anabataghị ọgwụ ndị dị na ọgwụ ahụ, insulinoma.
Mmetụta ndị ọ na-akpata: mmeghachi omume nfụkasị, lipodystrophy, hypoglycemia, hypoglycemic coma, mmebi nke nwa oge.
Doụbiga mmanya ókè: ịba ụba ike ọgwụgwụ, iro ụra na ike ọgwụgwụ, ị ,ụbiga ihe ọuseụuseụ ókè, palpitations, tachycardia, agụụ, ọnụ paresthesia, isi ọwụwa, vomiting na ọgbụgbọ, oke iwe na ọnọdụ obi mgbawa. Ahụhụ ọhụhụ anya, ihe ọdịdọ, glycemic coma.

Ọgwụ nke mgbaàmà ọjọọ na ịdoụbiga mmanya ókè mejupụtara subcutaneous, m / m ma ọ bụ iv nchịkwa nke glucagon, iv management nke hypertonic dextrose solution. Site na mmepe nke hypoglycemic coma, a na-egosipụta njikwa ụgbọelu intravenous nke 40 ml nke dextrose 40% ruo mgbe onye ọrịa ahụ si na Coma.

Ihe analog nke homonụ nke mmadụ nwere ịgwọ ọrịa ultrashort. Enwetara nkwadebe ahụ site na teknụzụ DNA ọzọ na-eji ọnya Saccharomyces cerevisiae. Ọ nwere mmetụta hypoglycemic. Ọ na-amalite ime ihe dị ka nkeji 10 ruo 20 mgbe nchịkwa subcutaneous wee rute kachasị na ọgwụgwọ ya mgbe awa 1-3 gachara.

A na-eji ya maka ọrịa mellitus nke mbụ na nke abụọ. A na-eji aspart naanị maka nchịkwa subcutaneous, usoro ọgwụ endocrinologist kpebisiri ike ị nweta ya. A na - egbochi ọgwụ ahụ maka hypoglycemia na hypersensitivity na mmiri. Ejighị ya agwọ ndị ọrịa na-erubeghị afọ isii, yana n'oge ime na lactation.

N'ihe banyere ịdoụbiga mmanya ókè, enwere akara nke hypoglycemia, nkwonkwo ma enwere ihe ize ndụ nke ịmalite ọrịa hypoglycemic. Iji wepu hypoglycemia dị nwayọ ma mezie ọnọdụ ahụ, o zuru ezu ị sugarụ shuga ma ọ bụ nri nwere nnukwu carbohydrates na-adị ngwa ngwa. N'ọnọdụ ndị ọzọ, ọ dị mkpa nchịkwa nchịkwa nke ngwakọta dextrose 40%.

, , , , , ,

Ngwọta maka nchịkwa subcutaneous. Ọ bụ mmeme nke insulin mmadụ, kwekọrọ na ya na ike nke ime ihe. Ọ mụbaa ọrụ, mana oge ọrụ dị mkpirikpi ma e jiri ya tụnyere hormone mmadụ.

A na-eji ya kwụọ ụgwọ metabolism dị n'ahụ na enweghị insulin. Anabatara maka iji ya na ọgwụgwọ nke ụmụaka karịrị afọ 6. Ejiri ya na nkeji iri na ise tupu nri ma ọ bụ tupu nri. Ọ bụ n’etiti ndị dibịa bekee ka dọkịta na-esite, ọ bụ onye ọrịa ọ bụla ka o kpebiri.
Ihe mgbochi: hypersensitivity na glulisin ma obu ihe ndi ozo nke ogwu. A na-eji nlekọta pụrụ iche maka ụmụ nwanyị dị ime na ndị ọrịa n’oge a na-enye nwa ara.
Mmetụta ọghọm: hypoglycemia na ọrịa metabolism ndị ọzọ, ọgbụgbọ na ọgbụgbọ, ịtalatalata, nhụ anya, ihe nfụkasị ahụ na ntanetị. N'ọnọdụ ndị a na-adịghị ahụkebe, ọ ga-ekwe omume ịmalite ụdị ọrịa akpịrị ịkpọ nkụ, mmetụta siri ike na obi, mmeghachi omume anaphylactic.
A na - egosipụta nrịrị ọ byụ byụ site na mgbaàmà nke hypoglycemia dị nro ma ọ bụ nke siri ike. N'okwu nke mbụ, egosi glucose ma ọ bụ ngwaahịa nwere shuga ka -ekwu maka ọgwụgwọ. N'okwu nke abụọ, a na-enye onye ọrịa ahụ ọsụsọ intramuscular ma ọ bụ ntinye nke glucagon ma ọ bụ dextrose.

Omume dị mkpirikpi (insulin dị mfe nke mmadụ) - ọgwụgwọ ọgwụgwọ na-etolite n'ime nkeji iri atọ na iri ise na ise mgbe nchịkwa gachara. Ọnụ ọgụgụ kachasị elu nke ọrụ na-ewe awa 1-4 ma na-adigide awa 5-8.

, , , , ,

Ngwọta Na - ahụ Maka Ihe Nchịkwa Mmadụ

Ngwọta ịgba ntụtụ nke gụnyere insulin injinịa mmadụ, glycerol, metacresol na ihe ndị ọzọ. O nwere obere hypoglycemic mmetụta. Ime ka ahụ banye n’ime ahụ na-eme ka ọ nwee onye na-anabata ihe n’elu akwara dị n’ọbara sel.

Na-akwalite ihiwe ogige nnabata insulin. Na-akpali usoro intracellular, njikọ nke enzymes isi. A na-ahụ ịmalite mmalite nke ọgwụ ahụ mgbe nkeji iri atọ gasịrị ka nchịkwa gasịrị, na nsonaazụ kachasị na-etolite n'ime awa 2-4, ogologo oge nke ihe ahụ bụ awa 6-8.

Ihe ngosi: oria oria 1 na oria n’enweghi nsogbu insulin, oria di iche-iche, onodu choro mmekpa ahu metabolism.
Usoro onunu ogwu na nhazi: subcutaneously, intramuscularly ma ọ bụ intravenously 30 nkeji tupu nri nwere nnukwu ọdịnaya nke carbohydrates. Usoro ubochi sitere na 0,5 ruo 1 IU / n'arọ ahụ.
Contraindications: hypersensitivity na mmiri ọgwụ, hypoglycemia, ịtụrụ ime na lactation.
Nsonaazụ: mmụba na ịba ụba, palpitations, ịma jijiji nke njedebe, agụụ, paresthesia na ọnụ na mgbaàmà ndị ọzọ hypoglycemic. Mmeghachi omume mpaghara: ọzịza n’ebe a na-agba ya, itching, lipodystrophy, mmeghachi omume nfụkasị ahụ, ọzịza.
Doụbiga ya ókè: nwere ihe mgbaàmà yiri mmeghachi omume ọjọọ. Site na mmepe nke steeti hypoglycemic, a na-atụ aro nri nwere carbohydrate, ma n'ọnọdụ ndị siri ike, iwebata usoro dextrose ma ọ bụ glucagon.

Biosulin dị na karama dị milimita iri abụọ na otu na katriiki nke 3 ml.

Ọgwụ na-akwụ ụgwọ maka ụkọ insulin nke na-arịa ọrịa shuga mellitus. Onwere otutu uzo di iche na insulin na protamine. Dị nke ọ bụla nwere ọgwụ ọgwụ nke ya, ya bụ, njirimara nke nkesa n'ime ahụ. Ejiri ụdị niile na-egosipụta ngwa ngwa mmalite na ogologo oge nke ihe.

Insuman Comb 15/85 - na-arụ ọrụ nkeji iri atọ na anọ ruo iri ise na ise mgbe nchịkwa gasịrị, oke ọgwụgwọ ọgwụgwọ na-etolite mgbe awa 3-5 gachara. Oge ọ ga-eme ihe bụ awa 11-20.
Insuman Comb 25/75 - amalite ime ihe nkeji iri atọ ka etinyere ngwa ahụ, nsonaazụ kachasị na-amalite mgbe awa 1.5-3 gachara, oge nke ime ihe bụ awa 12-18.
Insuman Comb 50/50 - na-eme ihe dị ka nkeji iri atọ mgbe nchịkwa gasịrị, a na-ahụ mmetụta kachasị ama mgbe awa 1-5.5 gasịrị, oge ọrụ ga-abụ awa 10-16.

A na-eji ya maka ụdị ọrịa shuga na-arịa ọrịa shuga. A na-achịkwa azịza ya n'okpuru obere elekere tupu nri. Ọtọ dọkịta setịpụrụ usoro onunu ogwu ahu.

Mmetụta ọghọm: mmeghachi ahụ nfụkasị anụ ahụ, lipodystrophy, nguzogide insulin, nrịanrịa akụrụ siri ike, mmeghachi omume hyperglycemic. Doụbiga ya ókè nwere otu ụdị ọrịa a na-ekwu maka ya. Contraindications: hypersensitivity na mmiri ọgwụ, coma mamịrị. Ọ dị n'ụdị nkwusioru maka ịgba ntụtụ na 10 ml 10 ọ bụla.

Ogwu nwere insulin nwere ihe eji eme ya na obere ihe. Mmetụta ọgwụgwọ ahụ na-etolite nkeji iri atọ mgbe nchịkwa gachara wee ruo na kacha n'ime awa 2-5. Mmetụta ọgwụgwọ na-adịru awa 6-8.

Ihe ngosiputa eji eme ihe: oria shuga insulin, omume nke ndi oria na anagide ndi ozo nke ogwu ahu, ogwugwo n’abia n’iru ndi oria udiri oria nke abuo, lipodystrophy.
Ofzọ itinye ya n'ọrụ: ọ bụrụ na enyere ọgwụ ahụ ọgwụ n'ụzọ dị ọcha, mgbe ahụ, a na-ahụ ya ugboro atọ n'ụbọchị subcutaneously, intramuscularly ma ọ bụ intravenously. Nkeji 30 mgbe ịgba ntụtụ ahụ, ịkwesịrị iri nri. A na-ekpebi usoro ọgwụgwọ ahụ site n'aka endocrinologist, iche iche maka ndị ọrịa ọ bụla.
Mmetụta ọghọm: mbelata nke ọbara shuga, na-acha ọbara ọbara n’ebe a na-agba ya na itching, mmeghachi ahụ anụ ahụ.
Contraindications: mbufụt homonụ nke pancreas, hypoglycemia. Ojiji n'oge afọ ime na lactation ga-ekwe omume naanị na ndenye ọgwụ.

Ntrapid NM dị na ampoules nke 10 ml nke ihe na-arụ ọrụ n'ime nke ọ bụla.

Brinsulrapi

Ọgwụ na-eme obere oge, na-egosi ọrụ ya nkeji iri atọ mgbe nchịkwa subcutaneous gasịrị. Mmetụta ọgwụgwọ kachasị na-amalite n'ime awa 1-3 wee dị ihe dị ka awa 8.

Ihe ngosiputa maka ojiji: oria 1 na oria abuo n’ime umuaka na ndi okenye, iguzogide ọgwụ hypoglycemic nke ogwu.
Uzo nke ntinye: a na-ekpebi usoro homonụ maka nlekọta nke subcutaneous site na dibia na-aga, otu maka onye ọrịa ọ bụla. A na-agwakọta azịza ya ozugbo nchịkọta yana ntụtụ. O buru na ubochi ubochi kariri 0.6 U / n'arọ, mgbe ahu ka ekewa ogwu ahu ka igba abuo ma gbanye ya n’ahu di iche.
Mmetụta ọghọm: rashes anụ ahụ, angioedema, ujo anafilactic, lipodystrophy, njehie na-efe efe oge, hyperemia anụ ahụ na saịtị ịgba.
Contraindications: anabataghị ihe ndị dị na ọgwụ ahụ, ọnọdụ hypoglycemic. Ọgwụgwọ n’oge ime na ịrara ga-ekwe omume naanị maka ebumnuche ọgwụ. A na-eji ya akpachapụ anya na ọnọdụ nke arụ ọrụ anụ ahụ ma ọ bụ nke uche.

, ,

Humodar P100

Insulin na-eme ka mmadụ dị mkpụmkpụ. Ọ na - emekọ ihe na ndị na - anabata mkpụrụ ndụ mejupụtara cytoplasmic, na - akpụ insulin-receptor complex nke na - akpali usoro intracellular.

Normalization nke glucose ọbara sitere na mmụba na mbuju intracellular nke homonụ a, mmetụ ahụ na - eme ka ọ dị nro nke uru ahụ. Ọgwụ na-amalite ime ihe dị ka nkeji iri atọ mgbe nchịkwa ahụ wee ruo karịa mgbe awa 1-2 gachara, ọgwụgwọ ahụ na-adịgide ruo awa 5-7.

Ihe ngosi maka ojiji: oria shuga nke udiri mbu na nke abuo. Elekere ma ọ bụ nguzogide zuru oke na ọgwụ hypoglycemic nke ọgwụ, ketoacidosis nke na-arịa ọrịa shuga, ọrịa mmegharị ahụ, ọrịa metabolic mgbe ị na-agbanye insulin arụ ọrụ ogologo oge.
Ofzọ nchịkwa na usoro onunu ogwu: ogwu a bu nke anakpo subcutaneous, intramuscular na intravenous management. Nkezi onwa ji ihe omuma aru sitere na 0,5 ruo 1 IU / kg. A na-eji homonụ ahụ nkeji iri atọ tupu nri bara ụba na carbohydrates. Ihe ngwọta a gbanyere mkpọrọgwụ kwesịrị ịdị n ’ụlọ okpomọkụ. Ọ bụrụ na enyere ọgwụ ahụ maka monotherapy, mgbe ahụ nchịkwa ugboro ole 3-5 ka ụbọchị.
Contraindications: ekweghị ibe nọrọ n'otu ọgwụ ahụ, ihe ịrịba ama nke hypoglycemia. Amachibidoro iji oge ime, inje n’oge eji ara ara ga-ekwe omume naanị maka ebumnuche ọgwụ.
Mmetụta ọghọm: blanching nke anụ ahụ, ịsụsọ dị elu, palpitations, ịma jijiji nke akụkụ ahụ niile, iwe iwe, ọgbụgbọ na ọgbụgbọ, isi ọwụwa. Ọ na - ekwe omume mmeghachi omume nfụkasị ahụ na ntụtụ.
Doụbiga ya ókè: ọnọdụ hypoglycemic nke ogo ịdị iche iche. Ọgwụgwọ mejupụtara shuga ma ọ bụ nri nwere carbohydrate. N'ọnọdụ siri ike, egosipụtara ntinye nke 40% nke dextrose ma ọ bụ glucagon.

A na-ewepụta Humodar P100 na vials 10 ml na cartridges nke 3 ml nke ọ bụla.

Berlinsulin N nkịtị U-40

Ọgwụ na mmetụta hypoglycemic. Na-ezo aka na ọgwụ nke ngwa-ngwa. Mmetụta ọgwụgwọ kachasị na-etolite mgbe awa 1-3 gachara were awa 6-8.

A na-eji ya agwọ ụdị ọrịa shuga niile na ọrịa shuga. Settọ usoro dobe iche maka onye ọrịa ọ bụla. Dịka iwu, a na-ahụ maka ọgwụ ọgwụ n'okpuru nkeji iri na ise tupu nri ugboro 3-4 n'ụbọchị. Thebọchị kwa ụbọchị bụ 6-20 nkeji. Maka ndị ọrịa nwere ọgwụ ike, a na-ebelata usoro onunu ogwu, na -echebe uche, ha na-abawanye.

A na - egbochi ọgwụ a maka ihe anabataghị ya na akụrụngwa hypoglycemia. A na - egosipụta nrịanrịa akụkụ site na mmeghachi omume anụ ahụ mpaghara, mmebi na ahụike n'ozuzu ya.

Ọkara Ogologo Insulins

Ji nwayọọ nwayọọ na-etinye obi gị dum ma na-enwe ọgwụgwọ ọgwụgwọ 1-2 awa mgbe ogwu ogbugba subcutaneous. A na-enweta nsonaazụ kachasị n'ime awa 4-12, oge nke ihe ahụ bụ awa 12-24.

Nkwụsịtụ maka nchịkwa okpuru ala. Ọ na - eme ka usoro phosphatidylinositol rụ ọrụ, na - agbanwe ụgbọ njem glucose. Ọ na-abawanye na potassium ịbanye na sel. 1 ml nke nkwusioru nwere 40 IU nke insulin mmadu nke sitere na biosynthetic. A na-eji ya maka mellitus na-arịa ọrịa shuga, maka ihe nfụkasị ụdị insulin ndị ọzọ, nsogbu vaskụla na-arịa ọrịa shuga.

A na-eji ọgwụ ahụ maka nchịkwa subcutaneous na intramuscular intramuscular. Ọ bụ n’etiti onye ọrịa ọ bụla na-ekpebi usoro onunu ogwu ya na ugboro ole ọ ga-agbatị. A na - agbarịta Isofan na hypoglycemic na coma. A na-egosipụta nsonaazụ ndị ọzọ site na mmetụta agụụ, ọrụ karịrị akarị, oke ụjọ, mmeghachi omume nfụkasị.

Monotard MS

Nkwadebe insulin nwere oge dị omimi. Nwere amorphous 30% na homonụ nke kristal 70%. Akụkụ nọ n'ọrụ bụ nkwụsị nke zinc nke insulin monoulinponent porcine insulin. Ọ na-amalite ime awa 2.5 mgbe nchịkwa gasịrị, nsonaazụ kachasị na-etolite mgbe awa 7-15 gachara ma nọgidesie ike maka otu ụbọchị.

Ihe ngosi maka iji: ụdị ụdị ọrịa shuga mellitus niile, iguzogide ndị ọrịa hypoglycemic nke ọnụ, nsogbu dị iche iche nke ọrịa shuga mellitus, ịwa ahụ, ime na lactation.
Ofzọ ntinye: dọkịta na-ahọrọ ọ̀kwa maka onye ọrịa ọ bụla. A na-agbanye ọgwụ ahụ n'ụzọ miri emi n'okpuru oge ọ bụla, ebe ọ na-agbanwe saịtị sirinji ahụ. Ọ bụrụ na usoro onunu ogwu akarị 0.6 U / n'arọ, mgbe ahụ ekwesịrị ịkesa ya abụọ injections dị iche iche. Ndị ọrịa na-anata ọgwụ karịrị ọgwụ iri 100 kwa ụbọchị ka a na-aga ụlọ ọgwụ.
Mmetụta ọghọm: ọnọdụ hypoglycemic nke ogo dị iche iche, precoma, coma. Hyperemia na ntụtụ ahụ, mmeghachi omume nfụkasị anụ ahụ.
Contraindications: ọnọdụ hypoglycemic na hypoglycemic coma.

Monotard MS dị n'ụdị nkwusioru nke ịgba ọgwụ mgbochi na vials 10 ml.

Insulong SPP

Hypoglycemic n'ụlọnga nke ọkara oge. A na-eji ya agwọ ọrịa shuga 1 na ụdị 2. A na - eji ọgwụ ahụ eme ihe maka irighiri irighiri irighiri akwara dị n'okpuru apata ụkwụ; A na-agbakọ usoro onunu ogwu site na endocrinologist, na-elekwasị anya n'ogo glucose na ọbara onye ọrịa na ihe ndị ọzọ nke ahụ ya.

A na-egbochi ọgwụ ahụ maka ọgwụ hypersensitivity na mmiri, hypoglycemia. A na-egosipụta mmetụta dị iche iche site na mmebi nke mgbatị ahụ. Ọ bụrụ na erighị nri na-edozi ahụ n'oge a na-agwọ ya ma ọ bụ na-eji ọgwụ ịba ụba, hypoglycemia nwere ike ịmalite. Mmeghachi omume mpaghara ọzọ nwere ike ịnweta ntụtụ: redness, ọzịza na itching.

Ogologo oge arụrụala

Ọ na - arụ ọrụ awa iri isii na isii gachara. Na-agbanyeghị, na-ebelata glucose ọbara. O nwere arụmọrụ kachasị elu a na-edeghị ede ọ na-arụkwa ọrụ ruo awa 24. Na-enye gị ohere inje 1 oge kwa ụbọchị.

Nkwadebe insulin na hypoglycemic nwere njiri arụ ọrụ bụ glargine (analog nke homonụ mmadụ). Ọ nwere solubility dị ala na gburugburu ebe anaghị anọpụ iche. Mgbe etinyere subcutaneously, a na-ewepụ acid a ma mepụta micropreprepre, na-ahapụ insulin.

Ihe ngosi maka ojiji: udiri oria insulin na-adi n’etiti ndi okenye na umuaka karia isii.
Ofzọ nke itinye n'ọrụ: a na-eme ogologo oge dabere na ntinye nke mpaghara nọ n'ọrụ n'ime abụba subcutaneous. Mmetụta ọgwụ a na-enye gị ohere iji ya otu ugboro n'ụbọchị. A na-agbakọ usoro onunu ogwu maka onye ọrịa ọ bụla.
Mmetụta ọghọm: ọrịa metabolic nke ogo dị iche iche. Ọtụtụ mgbe, a na-enwe mbelata nke acuity visual, lipoatrophy, lipohypertrophy, dysgeusia, mmeghachi omume nfụkasị mpaghara. N'ọnọdụ ndị na-adịghị ahụkebe, ujo anafilactic, myalgia, bronchospasm na-eme.
Contraindications: hypersensitivity na ọgwụ, hypoglycemia, mamịrị ketoacidosis. A naghị akwado ọgwụ ahụ maka ọgwụgwọ nke ndị inyom dị ime na ụmụaka.
Doụbiga ya ókè: ịghara itinye aka na usoro onunu ogwu ahụ na-etinye mmepe na ụdị hypoglycemia siri ike, nke dị ize ndụ nye onye ọrịa. Ọrịa na-adịghị ike na-akwụsị ị ofụ carbohydrates. N'ọnọdụ siri ike, a na-egosipụta njikwa ọbara nke ọgwụgwọ glucose dị ukwuu.

Lantus dị n'ụdị edozi maka injection, na katridges 3 ml.

Levemir Penfill

Antidiabetic na-ahụ maka ọrịa, analog nke hormone basal mmadụ na-arụ ọrụ ogologo oge. Mmetụta ogologo oge dabere na mmekọrịta nke ụmụ irighiri ihe nke ihe na-arụ ọrụ na albumin site na agbụ nke ọdụdụ abụba na ntụtụ. Mmetụta hypoglycemic na-adịgide ruo awa 24, mana ọ nwere ike ịdị iche iche dabere na usoro onunu ogwu. Ime ihe ahụ agbagoro na-enye ohere iji ọgwụ ahụ 1-2 ugboro n'ụbọchị.

A na-eji ya agwọ ọrịa shuga 1. A na-achịkwa azịza ya subcutaneously, a na-ahọrọ usoro onyonyo otu n'otu maka onye ọrịa ọ bụla, dabere na mkpa anụ ahụ ya na njiri mara ọrịa ahụ.
Mmetụta ọghọm: paler karịa nke anụ ahụ, ịma jijiji nke oke ya, ụjọ ịba ụba, nchekasị, ụra ụra, obi ọgbụgba ọsọ, mgbakasị ahụ anya na ọhụụ, paresthesia. Mmeghachi omume mpaghara n'ụdị anụ ahụ, itching, lipodystrophy na hyperemia nke anụ ahụ dịkwa ekwe omume. Dodoụbiga mmanya ókè nwere ọrịa ndị yiri ya. Ọgwụgwọ mejupụtara iri nri ndị nwere carbohydrate.
Ihe mgbochi: anabataghi aka nke ogwu ahu. Ojiji n'oge ime na ịrara nwa ga-ekwe omume naanị maka ebumnuche ọgwụ yana n'okpuru nlekọta siri ike nke endocrinologist.

Levemir Penfill dị na katridges 3 ml (nkeji 300) n'ụdị nke ihe edozi maka nchịkwa parenteral.

Tresiba FlexTouch

Ihe atụ nke homonụ nke mmadụ nke na - enweghị atụ. Usoro nke ị theụ ọgwụ ahụ si na mmekọrịta dị n'etiti ndị na - anabata ndị na - anabata insulin ụmụ mmadụ. Mmetụta hypoglycemic bụ n'ihi uru nke glucose site na anụ ahụ mgbe homonụ ahụ kekọtara ndị na-anabata abụba na akwara mkpụrụ ndụ.

A na-eji ọgwụ ahụ agwọ ọrịa shuga n’etiti ndị okenye na ndị na-eto eto, yana ụmụaka gbara afọ 1. A na-eji ihe ngwọta maka nchịkwa subcutaneous, a na-agbakọọ usoro ọgwụgwọ ahụ site n'aka dibịa na-aga, otu maka onye ọrịa ọ bụla.
Contraindications: anabataghị akụkụ nke ọgwụ, afọ ime na lactation.
Mmetụta ndị ọ na-akpata: hypoglycemia, mmeghachi omume nfụkasị ahụ na saịtị ịgba ahụ, lipodystrophy. Ọrịa sistemal ji alụ ọgụ, ọrịa akụkụ na ihe ịba mba na-ekwekwa omume. Dodoụbiga mmanya ókè nwere ọrịa ndị yiri ya. Iji wepu ihe mgbaàmà na-egbu mgbu, a na-atụ aro ị productsụ ngwaahịa nwere shuga n'ime. Ọ bụrụ na hypoglycemia dị n'ụdị siri ike, iwebata usoro dextrose dị mkpa.

Tresiba FlexTouch dị na sirinji maka iruu subcutaneous nke 100 na 200 nkeji / ml.

Na mgbakwunye na ọgwụ ọgwụ ndị a dị n'elu, enwere ngwakọta nke insulins nke ụdị dura dị iche iche: na-agafe NovoMix abụọ / 30/50, FlexPen, Penfill, Lizpro, abụọ na-enwe Humalog Mix 25/50.

Ihe ngosi na ntuziaka maka ojiji

A na - eji insulin Lizpro eme ihe n'ịgwọ ndị ọrịa nwere ọrịa shuga n'agbanyeghị agbụrụ na afọ. Ngwá ọrụ ahụ na-egosipụta ihe ngosi dị elu na ọnọdụ ebe onye ọrịa na-ebi ụdị ndụ na-adịghị mma, nke bụkarị maka ụmụaka.

Edere Humalog naanị site na ndị dibia bekee na:

1dị 1 na ụdị shuga mellitus 2 - na nke ikpeazụ, naanị mgbe ị takingụ ọgwụ ndị ọzọ anaghị eweta nsonaazụ ọma,
Hyperglycemia, nke ọgwụ ndị ọzọ anaghị eme ka nsogbu kwụsị,
Na-akwadebe onye ọrịa maka ịwa ahụ,
Mmegide nke ọgwụ ndị nwere insulin.
Ọnọdụ nke ọrịa pathologies na-agbagha usoro ọrịa ahụ.

Ofzọ nchịkwa ọgwụ nke onye nrụpụta tụrụ aro si dị subcutaneous, mana dabere n'ọnọdụ onye ọrịa, enwere ike inye gị ihe nnọchi anya intramuscularly na intravenously. Site n'ụdị subcutaneous, ebe kachasị adabara bụ hips, ubu, ihe nkwado na oghere afọ.

Nlekọta insulin Lizpro na-aga n'ihu n'otu ebe ahụ ka amachibidoro, n'ihi na nke a nwere ike ibute mmebi nke anụ ahụ n'ụdị lipodystrophy.

Enweghị ike iji otu akụkụ ahụ na-ahụ maka ọgwụ ahụ ihe karịrị 1 oge kwa ọnwa. Site na nchịkwa subcutaneous, enwere ike iji ọgwụ ahụ mee ihe na-enweghị ọnụnọ nke ọkachamara ahụike, mana ọ bụ naanị ma ọ bụrụ ọkachamara na-ahọrọ ọgwụ ahụ na mbụ.

Ọ bụ dibia bekee na-ahụ maka ịchekwa ọgwụ ọgwụ ahụ, a ga-elerịrị ya nke ọma - nke a ga - enyere ahụ aka imeghari na gọọmentị, yana iwepụta mmetụta ọgwụ ogologo oge.

Imeghari usoro a pụrụ ịchọ n'oge:

Gbanwe nri ma gbanwe ya na nri nwere oke carbohydrate, ma obu oke.
Nchegbu mmetụta uche
Ọrịa na-efe efe
Iji ọgwụ ọjọọ ndị ọzọ eme ihe
Na-agbanwe site na ọgwụ ndị ọzọ na-eme ngwa ngwa na-emetụta ọkwa glucose,
Ngosipụta nke ọdịda akụrụngwa,
Ime ime - dabere na oge ọkara, mkpa anụ ahụ insulin na-agbanwe, ya mere ọ dị mkpa
Gaa leta onye na-ahụ maka ahụike gị oge niile ma tụọ ọkwa shuga gị.

Ime mgbanwe gbasara usoro onunu ogwu ahu nwekwara ike idi nkpa mgbe ị na - agbanwe insulin Lizpro emeputa ya ma na - agbanwe n’etiti ndi ozo di iche, ebe obula n’ime ha n’eme mgbanwe nke aka ya n’ime ihe mejuputara ya, o nwere ike imuta oru ọgwụgwọ a.

Nsonaazụ na contraindications

Mgbe ị na-ahọpụta ọgwụ, dọkịta na-ahụ maka ịga kwesịrị ịtụle njirimara niile nke ahụ onye ọrịa.

A na - egbochi insulin Lizpro n'ime ndị mmadụ:

Site na nwetakịrị uche dị na mpaghara ma ọ bụ mpaghara ndị ọzọ na-arụ ọrụ,
N'ịba ụba nke hypoglycemia,
N'ime ya ka insulinoma dị.

N'oge ị ofụ ọgwụ ọjọọ na ndị ọrịa mamịrị, enwere ike ịhụ nsonaazụ ndị a:

Ọrịa hypoglycemia - bụ nke kachasị dị ize ndụ, na-apụta n'ihi ọgwụ ahọrọghị nke ọma, yana iji ọgwụ onwe gị, nwere ike ibute ọnwụ ma ọ bụ nnukwu nsogbu nke ọrụ ụbụrụ,
Lipodystrophy - na - apụta n'ihi injections n'otu mpaghara ahụ, maka mgbochi, ọ dị mkpa iji uzo ọzọ akpụkpọ ahụ tụrụ aro ya,
Allergy - gosipụtara onwe ya dabere na njirimara nke ahụ nke onye ọrịa, na-amalite site na ncha uhie uhie nke saịtị ịgba ahụ, na-ejedebe na ụjọ anaphylactic,
Ọgba aghara nke ngwa anya - na uru na-ezighi ezi ma ọ bụ anabataghị ihe nke akwara, retinopathy (mmebi nke oghere nke anya n'ihi ọrịa vaskụla) ma ọ bụ akụkụ elele acuity visual, ọtụtụ mgbe na-egosipụta onwe ya na nwata ma ọ bụ mebie usoro obi.
Mmeghachi omume mpaghara - na ntụtụ, ọbara ọbara, itching, ọbara-ọbara na ọzịza nwere ike ime, na-agafe mgbe anụ ahụ mechara.

Ọrịa ụfọdụ nwere ike ịmalite ịpụta mgbe ogologo oge gachara. Maka ụdị mmetụta ọ bụla, kwụsị ị sideụ insulin ma kpọtụrụ dọkịta gị. A na-edozi ọtụtụ nsogbu site na ndozi dose.

Mmekọrịta na ọgwụ ndị ọzọ

Mgbe ị na-ede ọgwụ Humalog, dibia bekee ga-elebara ọgwụ ị already na-ewere. Offọdụ n'ime ha nwere ike ịkwalite ma belata ọrụ insulin.

A na - eme ka mmetụta insulin Lizpro dịkwuo mma ma ọ bụrụ na onye ọrịa ahụ ewere ọgwụ na otu ndị a:

MAO Inhibitors,
Sulfonamides,
Ketoconazole,
Sulfonamides.

Site n'iji ọgwụ ndị ọzọ mee ihe, ọ dị mkpa iji belata ọgwụ insulin, onye ọrịa kwesịrị, ma ọ bụrụ na ọ ga-ekwe omume, jụrụ ị themụ ya.

Ihe ndị na-esonụ nwere ike belata arụmọrụ Insulin Lizpro:

Ihe mgbochi homonụ
Estrogens
Glucagon,
Nicotine.

Usoro ị insụ insulin nọ n'ọnọdụ a kwesịrị ịba ụba, ma ọ bụrụ na onye ọrịa ahụ ejiri ọgwụ ndị a, ọ ga-adị mkpa ime mgbanwe nke abụọ.

Ọ dịkwa mma ịtụle ụfọdụ atụmatụ n'oge ọgwụgwọ insulin Lizpro:

Mgbe ị na-agbakọ usoro onunu ogwu, dibia ga-elele etu na ụdị nri onye ọrịa ahụ na -eri,
N’oge ọrịa imeju na akụrụ na-adịghị ala ala, ọ ga-adị mkpa ka e belata ọgwụ ahụ,
Humalog nwere ike belata ọrụ nke mmụba akwara, nke na-emetụta ọnụego mmeghachi omume, nke a na-ewetakwa ndị nwe ụgbọ ala ihe egwu, dịka ọmụmaatụ.

Insulin Lizpro (Humalog) nwere oke onu ahia zuru oke, n'ihi nke ndi oria na-acho ndi analogues.

Enwere ike ịchọta ọgwụ ndị a na-ere ahịa n'ahịa nwere otu ụkpụrụ omume:

Monotard
Protafan
Rinsulin
Intal
Arụ Ọrụ.

Amachibidoro ya iwu iwere ọgwụ kwụsịrị onwe ya. Ihe mbụ ị ga - eme bụ inweta ndụmọdụ n’aka dọkịta gị, ebe ị -ụ ọgwụ onwe gị nwere ike ibute ọnwụ.

Ọ bụrụ n’ị na-enwe obi abụọ banyere ike ihe onwunwe gị, dọọ ọkachamara aka na ntị gbasara nke a. Nhazi nke ọgwụ ọ bụla nwere ike ịdị iche dabere na onye nrụpụta, n'ihi nke ike nke mmetụta ọgwụ nwere n'ahụ ahụ onye ọrịa ga-agbanwe.

A na-ejikarị ọgwụgwọ a maka ụdị ọrịa shuga na-abụghị insulin na-akpata (1 na 2) yana ọgwụgwọ maka ụmụaka na ụmụ nwanyị dị ime. Site na ngụkọta usoro ziri ezi, Humalog anaghị akpata nsonaazụ ma jiri nwayọ na-emetụta ahụ.

Enwere ike ịnye ọgwụ ahụ n'ọtụtụ ụzọ, mana ihe kachasị bụ subcutaneous, na ụfọdụ ndị nrụpụta na-enye ngwá ọrụ ahụ na injectionor pụrụ iche nke mmadụ nwere ike iji ọbụna n'ọnọdụ akwụghị chịm.

Ọ bụrụ na ọ dị mkpa, onye ọrịa nwere ọrịa shuga nwere ike ịchọta ọgwụ analogues na ọgwụ ọgwụ, mana na-enweghị ndụmọdụ na ọkachamara na ya, a machibidoro iji ojiji ha iwu. Insulin Lizpro dakọtara na ọgwụ ndị ọzọ, mana n'ọnọdụ ụfọdụ, achọrọ ịmegharị dose.

Iji ọgwụ a eme ihe mgbe niile abụghị ihe na-eri ahụ, mana onye ọrịa ahụ ga-agbaso usoro pụrụ iche nke ga-enyere ahụ ahụ aka imeghari n'ọnọdụ ọhụrụ.

Uzo esi ewere INSULIN LIZPRO

A na-eme ntụtụ ahụ n'okpuru akpụkpọ ahụ n'ime afọ, ubu, apata ma ọ bụ isi. O di nkpa iji saịtị ozo igba ozo ka ịghara igba otu ebe karia otu ugboro kwa onwa. Ekwesịrị ilezi anya mgbe ị na-agba ntụtụ ka ọ ghara imebi arịa ọbara. Amachibidoro ị drugụ ọgwụ ahụ n'ụzọ ọ bụla karịa ịgba ọgwụ mgbochi.

Ihe ngbanwe

Ọgwụ "Insulin Lizpro" nwere ụfọdụ contraindications maka iji ya:

mmadu anabataghi ya,
ọnụnọ nke akpụ na pancreas,
ọbara ọgbụgba dị ala

Na ọnụnọ nke ọrịa ịba ọcha n'anya ma ọ bụ akụrụ, amachibido ọgwụ a maka iji ya, mana a ga-aharịrị olu ya mgbe niile.

Nsonaazụ

N'iji ọgwụ insulin Lizpro, onye ọrịa ahụ kwesịrị ịdị njikere maka ọdịdị nke mmetụta ụfọdụ, gosipụtara n'ụdị nke allergies, ntakịrị ahụ ọkụ, nkwarụ anya, glucose ọbara na-ebelata, na ịta ahụ oke. Dodoụbiga ọgwụ a ókè nwere ike ime ka nsogbu ọgbụgba, oke iwe, ehighị ụra nke ọma, isi ọwụwa, ọhụhụ na-egbu mgbu, ihe na-eduga ná mmiri.